Page last updated: 2024-08-26

sn 38 and 10,11-methylenedioxy-20-camptothecin

sn 38 has been researched along with 10,11-methylenedioxy-20-camptothecin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fan, Y; Kohn, KW; Pommier, Y; Shi, LM; Weinstein, JN1
Bearss, D; Manikumar, G; Von Hoff, DD; Wadkins, RM; Wall, ME; Wani, MC1

Other Studies

2 other study(ies) available for sn 38 and 10,11-methylenedioxy-20-camptothecin

ArticleYear
Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.
    Journal of medicinal chemistry, 1998, Jun-18, Volume: 41, Issue:13

    Topics: Amino Acid Substitution; Antineoplastic Agents; Binding Sites; Camptothecin; DNA; DNA Topoisomerases, Type I; Drug Resistance, Neoplasm; Enzyme Inhibitors; Hydrogen Bonding; Ligands; Models, Molecular; Molecular Conformation; Mutation; Protein Conformation; Stereoisomerism; Structure-Activity Relationship; Thermodynamics; Topoisomerase I Inhibitors

1998
Camptothecin analogs with bulky, hydrophobic substituents at the 7-position via a Grignard reaction.
    Bioorganic & medicinal chemistry letters, 2004, Nov-01, Volume: 14, Issue:21

    Topics: Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Ketones; Structure-Activity Relationship; Topoisomerase I Inhibitors

2004